- Home
- SPCE vs SGMO Comparison
SPCE vs SGMO Comparison
Compare SPCE & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPCE
- SGMO
- Stock Information
- Founded
- SPCE 2017
- SGMO 1995
- Country
- SPCE United States
- SGMO United States
- Employees
- SPCE N/A
- SGMO N/A
- Industry
- SPCE Transportation Services
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SPCE Consumer Discretionary
- SGMO Health Care
- Exchange
- SPCE Nasdaq
- SGMO Nasdaq
- Market Cap
- SPCE 187.1M
- SGMO 488.2M
- IPO Year
- SPCE N/A
- SGMO 2000
- Fundamental
- Price
- SPCE $6.54
- SGMO $1.30
- Analyst Decision
- SPCE Hold
- SGMO Buy
- Analyst Count
- SPCE 6
- SGMO 5
- Target Price
- SPCE $25.50
- SGMO $5.20
- AVG Volume (30 Days)
- SPCE 1.7M
- SGMO 10.6M
- Earning Date
- SPCE 02-25-2025
- SGMO 11-12-2024
- Dividend Yield
- SPCE N/A
- SGMO N/A
- EPS Growth
- SPCE N/A
- SGMO N/A
- EPS
- SPCE N/A
- SGMO N/A
- Revenue
- SPCE $9,416,000.00
- SGMO $52,291,000.00
- Revenue This Year
- SPCE $5.88
- SGMO N/A
- Revenue Next Year
- SPCE N/A
- SGMO $9.31
- P/E Ratio
- SPCE N/A
- SGMO N/A
- Revenue Growth
- SPCE 93.74
- SGMO N/A
- 52 Week Low
- SPCE $5.27
- SGMO $0.30
- 52 Week High
- SPCE $48.60
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- SPCE 52.27
- SGMO 36.95
- Support Level
- SPCE $5.94
- SGMO $0.91
- Resistance Level
- SPCE $6.77
- SGMO $2.73
- Average True Range (ATR)
- SPCE 0.43
- SGMO 0.32
- MACD
- SPCE 0.01
- SGMO -0.15
- Stochastic Oscillator
- SPCE 71.57
- SGMO 20.21
About SPCE Virgin Galactic Holdings Inc.
Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures advanced air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day, and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.